Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardent Health (ARDT) Cash from Financing Activities: 2022-2024

Historic Cash from Financing Activities for Ardent Health (ARDT) over the last 3 years, with FY2024 value amounting to $24.6 million.

  • Ardent Health's Cash from Financing Activities fell 11468.23% to -$26.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$80.2 million, marking a year-over-year decrease of 40123.87%. This contributed to the annual value of $24.6 million for FY2024, which is 12409.69% up from last year.
  • As of FY2024, Ardent Health's Cash from Financing Activities stood at $24.6 million, which was up 12409.69% from -$102.3 million recorded in FY2023.
  • Ardent Health's 5-year Cash from Financing Activities high stood at $24.6 million for FY2024, and its period low was -$270.3 million during FY2022.
  • Over the past 3 years, Ardent Health's median Cash from Financing Activities value was -$102.3 million (recorded in 2023), while the average stood at -$116.0 million.
  • In the last 5 years, Ardent Health's Cash from Financing Activities surged by 6217.16% in 2023 and then soared by 12409.69% in 2024.
  • Annual analysis of 3 years shows Ardent Health's Cash from Financing Activities stood at -$270.3 million in 2022, then skyrocketed by 62.17% to -$102.3 million in 2023, then skyrocketed by 124.1% to $24.6 million in 2024.
  • Its last three reported values are $24.6 million in FY2024, -$102.3 million for FY2023, and -$270.3 million during FY2022.